These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 24622786

  • 1. 5-HT6 receptor antagonists as treatment for age-related cognitive decline.
    Quiedeville A, Boulouard M, Da Silva Costa-Aze V, Dauphin F, Bouet V, Freret T.
    Rev Neurosci; 2014; 25(3):417-27. PubMed ID: 24622786
    [Abstract] [Full Text] [Related]

  • 2. Serotonin 5-HT6 receptor antagonists for the treatment of cognitive deficiency in Alzheimer's disease.
    Benhamú B, Martín-Fontecha M, Vázquez-Villa H, Pardo L, López-Rodríguez ML.
    J Med Chem; 2014 Sep 11; 57(17):7160-81. PubMed ID: 24850589
    [Abstract] [Full Text] [Related]

  • 3. 5-HT6 receptor blockade differentially affects scopolamine-induced deficits of working memory, recognition memory and aversive learning in mice.
    Da Silva Costa-Aze V, Quiedeville A, Boulouard M, Dauphin F.
    Psychopharmacology (Berl); 2012 Jul 11; 222(1):99-115. PubMed ID: 22367167
    [Abstract] [Full Text] [Related]

  • 4. The serotonin 5-HT6 receptor: a viable drug target for treating cognitive deficits in Alzheimer's disease.
    Geldenhuys WJ, Van der Schyf CJ.
    Expert Rev Neurother; 2009 Jul 11; 9(7):1073-85. PubMed ID: 19589055
    [Abstract] [Full Text] [Related]

  • 5. 5-HT6 receptor ligands, EMD386088 and SB258585, differentially regulate 5-HT6 receptor-independent events.
    Yun HM, Rhim H.
    Toxicol In Vitro; 2011 Dec 11; 25(8):2035-40. PubMed ID: 21864673
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The procognitive effects of 5-HT6 receptor ligands in animal models of schizophrenia.
    Nikiforuk A.
    Rev Neurosci; 2014 Dec 11; 25(3):367-82. PubMed ID: 24501158
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. AVN-492, A Novel Highly Selective 5-HT6R Antagonist: Preclinical Evaluation.
    Ivachtchenko AV, Okun I, Aladinskiy V, Ivanenkov Y, Koryakova A, Karapetyan R, Mitkin O, Salimov R, Ivashchenko A.
    J Alzheimers Dis; 2017 Dec 11; 58(4):1043-1063. PubMed ID: 28550249
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Chronic activation of 5-HT4 receptors or blockade of 5-HT6 receptors improve memory performances.
    Quiedeville A, Boulouard M, Hamidouche K, Da Silva Costa-Aze V, Nee G, Rochais C, Dallemagne P, Fabis F, Freret T, Bouet V.
    Behav Brain Res; 2015 Oct 15; 293():10-7. PubMed ID: 26187692
    [Abstract] [Full Text] [Related]

  • 15. 5-HT6 receptors: a novel target for cognitive enhancement.
    Mitchell ES, Neumaier JF.
    Pharmacol Ther; 2005 Dec 15; 108(3):320-33. PubMed ID: 16005519
    [Abstract] [Full Text] [Related]

  • 16. Dual-acting agents for improving cognition and real-world function in Alzheimer's disease: Focus on 5-HT6 and D3 receptors as hubs.
    Millan MJ, Dekeyne A, Gobert A, Brocco M, Mannoury la Cour C, Ortuno JC, Watson D, Fone KCF.
    Neuropharmacology; 2020 Oct 15; 177():108099. PubMed ID: 32525060
    [Abstract] [Full Text] [Related]

  • 17. 5-HT6 Receptor: A New Player Controlling the Development of Neural Circuits.
    Dayer AG, Jacobshagen M, Chaumont-Dubel S, Marin P.
    ACS Chem Neurosci; 2015 Jul 15; 6(7):951-60. PubMed ID: 25590789
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Drug targets for cognitive enhancement in neuropsychiatric disorders.
    Wallace TL, Ballard TM, Pouzet B, Riedel WJ, Wettstein JG.
    Pharmacol Biochem Behav; 2011 Aug 15; 99(2):130-45. PubMed ID: 21463652
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.